Met Life Investment Management, LLC Reata Pharmaceuticals Inc Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

40 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Apr 29, 2024	BUY	$79.22 - $105.37 $1.19 Million - $1.59 Million	15,065 New	15,065 $1.54 Million
Q2 2023 Aug 10, 2023	BUY	$79.22 - $105.37 $49,116 - $65,329	620 Added 4.29%	15,065 $1.54 Million
Q1 2023 May 09, 2024	BUY	$30.85 - $93.17 $445,628 - $1.35 Million	14,445 New	14,445 $1.31 Billion
Q1 2023 May 15, 2023	SELL	$30.85 - $93.17 $16,227 - $49,007	-526 Reduced 3.51%	14,445 $1.31 Million
Q4 2022 May 10, 2024	SELL	$22.15 - $42.11 $13,733 - $26,108	-620 Reduced 3.98%	14,971 $568,000
Q4 2022 Jun 14, 2023	BUY	$22.15 - $42.11 $11,650 - $22,149	526 Added 3.64%	14,971 $568,000
Q4 2022 Mar 22, 2023	SELL	$22.15 - $42.11 $13,733 - $26,108	-620 Reduced 3.98%	14,971 $568,000
Q4 2022 Feb 15, 2023	SELL	$22.15 - $42.11 $13,733 - $26,108	-620 Reduced 3.98%	14,971 $568,000
Q3 2022 Jun 14, 2023	BUY	$19.41 - $36.49 $22,243 - $41,817	1,146 Added 7.93%	15,591 $391,000
Q2 2022 Jun 20, 2023	BUY	$20.71 - $36.5 $23,733 - $41,829	1,146 Added 7.93%	15,591 $473,000
Q1 2022 May 10, 2024	BUY	$24.12 - $39.6 $376,054 - $617,403	15,591 New	15,591 $510,000
Q1 2022 Jun 20, 2023	BUY	$24.12 - $39.6 $27,641 - $45,381	1,146 Added 7.93%	15,591 $510,000
Q1 2022 Mar 22, 2023	BUY	$24.12 - $39.6 $138,786 - $227,858	5,754 Added 58.49%	15,591 $510,000
Q1 2022 May 12, 2022	BUY	$24.12 - $39.6 $138,786 - $227,858	5,754 Added 58.49%	15,591 $511,000
Q4 2021 Jun 21, 2023	SELL	$25.61 - $110.96 $118,010 - $511,303	-4,608 Reduced 31.9%	9,837 $259,000
Q3 2021 Jun 21, 2023	SELL	$100.0 - $143.02 $460,800 - $659,036	-4,608 Reduced 31.9%	9,837 $989,000
Q2 2021 May 17, 2024	BUY	$78.27 - $151.29 $769,941 - $1.49 Million	9,837 New	9,837 $1.39 Million
Q2 2021 Jun 21, 2023	SELL	$78.27 - $151.29 $360,668 - $697,144	-4,608 Reduced 31.9%	9,837 $1.39 Million
Q2 2021 Mar 22, 2023	BUY	$78.27 - $151.29 $765,637 - $1.48 Million	9,782 Added 17785.45%	9,837 $1.39 Million
Q2 2021 Aug 16, 2021	BUY	$78.27 - $151.29 $765,637 - $1.48 Million	9,782 Added 17785.45%	9,837 $1.39 Million
Q1 2021 Mar 22, 2023	SELL	$94.25 - $132.81 $890,851 - $1.26 Million	-9,452 Reduced 99.42%	55 $5,000
Q1 2021 May 14, 2021	BUY	$94.25 - $132.81 $5,183 - $7,304	55 New	55 $5,000
Q2 2020 Aug 14, 2020	SELL	$126.3 - $176.56 $1.2 Million - $1.68 Million	-9,507 Closed	0 $0
Q1 2020 Jul 12, 2023	SELL	$124.16 - $247.74 $613,102 - $1.22 Million	-4,938 Reduced 34.18%	9,507 $1.37 Million
Q4 2019 Jul 12, 2023	SELL	$74.57 - $217.92 $368,226 - $1.08 Million	-4,938 Reduced 34.18%	9,507 $1.94 Million
Q4 2019 Mar 22, 2023	BUY	$74.57 - $217.92 $28,709 - $83,899	385 Added 4.22%	9,507 $1.94 Million
Q4 2019 Feb 14, 2020	BUY	$74.57 - $217.92 $28,709 - $83,899	385 Added 4.22%	9,507 $1.94 Million
Q3 2019 Jul 12, 2023	SELL	$71.26 - $95.75 $379,316 - $509,677	-5,323 Reduced 36.85%	9,122 $732,000
Q3 2019 Mar 22, 2023	BUY	$71.26 - $95.75 $52,803 - $70,950	741 Added 8.84%	9,122 $732,000
Q3 2019 Nov 14, 2019	BUY	$71.26 - $95.75 $52,803 - $70,950	741 Added 8.84%	9,122 $732,000
Q2 2019 Jul 12, 2023	SELL	$77.72 - $94.35 $413,703 - $502,225	-5,323 Reduced 36.85%	9,122 $860,000
Q1 2019 Jul 13, 2023	SELL	$51.9 - $101.79 $314,721 - $617,254	-6,064 Reduced 41.98%	8,381 $716,000
Q4 2018 Jul 13, 2023	SELL	$48.76 - $76.44 $295,680 - $463,532	-6,064 Reduced 41.98%	8,381 $470,000
Q4 2018 Mar 22, 2023	SELL	$48.76 - $76.44 $231,171 - $362,402	-4,741 Reduced 36.13%	8,381 $470,000
Q4 2018 Feb 14, 2019	SELL	$48.76 - $76.44 $231,171 - $362,402	-4,741 Reduced 36.13%	8,381 $470,000
Q3 2018 Jul 13, 2023	SELL	$35.64 - $92.06 $216,120 - $558,251	-6,064 Reduced 41.98%	8,381 $685,000
Q3 2018 Mar 22, 2023	SELL	$35.64 - $92.06 $65,898 - $170,218	-1,849 Reduced 12.35%	13,122 $1.07 Million
Q3 2018 Nov 14, 2018	BUY	$35.64 - $92.06 $192,099 - $496,203	5,390 Added 69.71%	13,122 $1.07 Million
Q2 2018 Aug 15, 2018	BUY	$19.94 - $40.96 $64,904 - $133,324	3,255 Added 72.7%	7,732 $270,000
Q4 2017 Feb 15, 2018	BUY	$22.39 - $33.27 $100,240 - $148,949	4,477	4,477 $127,000

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account